Bing Wang, Founder of Amador Bioscience

Bing Wang is the founder of Amador Bioscience. Amador Bioscience has raised $100M in total funding. Latest round: Series B.

About Bing Wang

Dr. Bing Wang is the Chairman and CEO of Amador Bioscience, a global contract research organization (CRO) specializing in translational science and clinical pharmacology. The company provides services such as bioanalysis, clinical pharmacology, regulatory affairs, and clinical research. Amador Bioscience recently secured over $60 million in Series B+ financing, following closely on its Series B round. The company is actively expanding its global presence, establishing branches in Shanghai, new laboratory facilities in California and Maryland, and a European subsidiary in Belgium. Amador Bioscience also acquired Ann Arbor Pharmacometrics Group (A2PG) to enhance its clinical pharmacology services.

Bing Wang at a glance

More founders in Pleasanton, California, USA (28)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades